View Future GrowthThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsSteep Hill 과거 순이익 실적과거 기준 점검 0/6Steep Hill은 연평균 32.5%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 8.8%의 비율로 증가했습니다. 매출은 연평균 20.8%의 비율로 감소했습니다.핵심 정보32.54%순이익 성장률57.17%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률7.33%매출 성장률-20.82%자기자본이익률-11.68%순이익률n/a최근 순이익 업데이트30 Sep 2025최근 과거 실적 업데이트Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).모든 업데이트 보기Recent updates공시 • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.공시 • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.공시 • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.공시 • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.공시 • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.공시 • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.Board Change • Jul 26High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. 2 experienced directors. No highly experienced directors. Independent Director Ian Morton is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.New Risk • Jun 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€326.3k market cap, or US$354.5k).공시 • Apr 24Steep Hill Inc., Annual General Meeting, Jul 26, 2024Steep Hill Inc., Annual General Meeting, Jul 26, 2024.New Risk • Apr 17New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (67% average weekly change). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€275.4k market cap, or US$293.9k).Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).공시 • Jul 06Steep Hill Inc. Announces Demise of Director, David WaltersThe Board of Directors and management of Steep Hill Inc. announce that Director, David Walters, has passed away. David joined the board at the time of the go-public transaction of Canbud Distribution Corp., (now called Steep Hill Inc) and during his time with the company provided oversight as Audit Committee chair. On behalf of the Board of Directors and team, company extend the deepest condolences to David's family and to all those who came to know him as a colleague and as a friend.공시 • Jun 04Steep Hill Inc. Announces Chief Financial Officer ChangeSteep Hill Inc. announced that Raj Ravindran has resigned as the company's Chief Financial Officer to pursue other endeavors. Raj was one of the co-founders of Canbud Distribution Corp., the entity that culminated into Steep Hill following the acquisitions made in 2021 and 2022. The board announced the appointment of Ms. Patricia Militello as Interim CFO. Since fourth quarter of 2021, Ms. Militello has been instrumental in leading the finance and accounting team as an external consultant. Ms. Militello is expected to lend her expertise as Steep Hill continues on the path of restructuring and exploring strategic alternatives.공시 • May 19Steep Hill Inc., Annual General Meeting, Jul 28, 2023Steep Hill Inc., Annual General Meeting, Jul 28, 2023.Board Change • Dec 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 3 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Mar 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.매출 및 비용 세부 내역Steep Hill가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:CD0 매출, 비용 및 순이익 (CAD Millions)날짜매출순이익일반관리비연구개발비30 Sep 25000030 Jun 25000031 Mar 25000031 Dec 24000030 Sep 24000030 Jun 24000031 Mar 24000031 Dec 23000030 Sep 231-42130 Jun 230-31031 Mar 231-42031 Dec 221-42130 Sep 221-32030 Jun 222-53131 Mar 221-43131 Dec 211-53030 Sep 210-43030 Jun 210-33031 Mar 210-33031 Dec 200-22030 Sep 200-11030 Jun 200-11031 Mar 200-110양질의 수익: CD0 은(는) 현재 수익성이 없습니다.이익 마진 증가: CD0는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: CD0는 수익성이 없지만 지난 5년 동안 연평균 32.5%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 CD0의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: CD0은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(16.1%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: CD0는 현재 수익성이 없으므로 자본 수익률이 음수(-11.68%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/02/10 18:42종가2025/11/13 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Steep Hill Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).
Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).
공시 • May 16Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 1.8 million in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As of December 19, 2025, the parties entered into an amending agreement such that Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-consolidation common shares of the Resulting Issuer, based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 30,818,614 Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws. Steep Hill Inc. board recommend the transaction. The special meeting of shareholders of Steep Hill will be held to approve the transaction on March 26, 2026. As of March 26, 2026, the parties extended the outside date for completion of the transaction to May 7, 2026. Endeavor Trust Corporation acted as transfer agent for Steep Hill Inc. Good Purpose Investments Inc. completed the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on May 14, 2026. Upon completion of the Transaction, 7.36% of the Common Shares being held by shareholders of Steep Hill Inc. and 92.64% of the Common Shares being held by GPI shareholders. Steep Hill Inc. changed its name to Good Purpose Investments Inc. The Common Shares are expected to commence trading on the CSE under the new name and the new ticker symbol “GPIN” as of market open on May 19, 2026. Concurrently with Closing, the board of directors of Steep Hill Inc. was reconstituted to consist of Monique Maissan, Max Whiffin, Hani Zabaneh and Sameet Kanade. George Tsogas has been appointed Chief Executive Officer, Melissa Kinnoch has been appointed Chief Financial Officer and Corporate Secretary, Monique Maissan has been appointed Chief Development Officer and Max Whiffin has been appointed Vice President, Corporate Development.
공시 • Nov 14Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Good Purpose Investments Inc. entered into an agreement to acquire Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on November 12, 2025. Good Purpose shareholders will exchange all of the common shares of Good Purpose for post-Consolidation common shares of the Resulting Issuer based on an exchange ratio equal to one Resulting Issuer Shares for each one Good Purpose Share to a maximum of 62 million Resulting Issuer Shares. As such, the Transaction will result in a reverse takeover of the Steep Hill by the shareholders of Good Purpose upon completion of the Transaction, and the Resulting Issuer’s primary business will be the business of Good Purpose. In connection with the Transaction, the Steep Hill intends to: (i) change its name to “Good Purpose Investments Inc.” or such other name as the Steep Hill and Good Purpose may mutually agree; (ii) change its stock exchange ticker symbol to a symbol to be determined between the parties and acceptable to the CSE; (iii) consolidate its issued and outstanding common shares on the basis of one post consolidation common shares for every three pre-consolidation common shares of the Steep Hill; and (iv) reconstitute its board of directors and management team. Completion of the Transaction is subject to a number of terms and conditions customary for transactions of this nature, including, among other things, Good Purpose having completed the Good Purpose Financing receipt of all necessary shareholder and regulatory approvals contemplated in the Amalgamation Agreement, the execution of related transaction documents, and listing approval of the CSE. In addition, the Transaction must be approved by not less than 66?% of the votes cast at a meeting of shareholders of Good Purpose. The Company will also seek approval of the Transaction, the Name Change and the Consolidation at a meeting of the Steep Hill's shareholders. Certain securities issued in connection with the Transaction will be subject to escrow requirements of the CSE, mutually agreed upon escrow conditions, and hold periods as required by the CSE and applicable securities laws.
공시 • Jul 04Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing. Lir Life Sciences Inc. cancelled the acquisition of Steep Hill Inc. (CNSX:STPH) in a reverse merger transaction on July 3, 2025.
공시 • Apr 02Steep Hill Inc., Annual General Meeting, May 15, 2025Steep Hill Inc., Annual General Meeting, May 15, 2025.
공시 • Mar 05Steep Hill Inc., Annual General Meeting, Apr 07, 2025Steep Hill Inc., Annual General Meeting, Apr 07, 2025.
공시 • Feb 14Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction.Lir Life Sciences Inc. entered into a share purchase agreement to acquire Steep Hill Inc. (CNSX:STPH) for CAD 8.2 million in a reverse merger transaction on February 12, 2025. As part of the consideration, 136,054,422 common shares of Steep Hill issued at the price of CAD 0.147. Lir will be required to complete an equity financing for proceeds of at least CAD 1,000,000 concurrently with the closing of the Acquisition, and the Company’s shares will be consolidated on a 3-for-1 basis immediately following completion of the Acquisition and Concurrent Financing. Concurrently with the completion of the Acquisition, all current Directors of the Company, except for Mr. Sameet Kanade, will resign and be replaced by nominees of LIR. The transaction is subject to the approval of target's shareholders, regulatory approvals and the consummation of concurrent financing.
Board Change • Jul 26High number of new and inexperienced directorsThere are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. 2 experienced directors. No highly experienced directors. Independent Director Ian Morton is the most experienced director on the board, commencing their role in 2021. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
New Risk • Jun 04New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (52% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€326.3k market cap, or US$354.5k).
공시 • Apr 24Steep Hill Inc., Annual General Meeting, Jul 26, 2024Steep Hill Inc., Annual General Meeting, Jul 26, 2024.
New Risk • Apr 17New major risk - Revenue sizeThe company makes less than US$1m in revenue. This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (67% average weekly change). Earnings have declined by 36% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€275.4k market cap, or US$293.9k).
Reported Earnings • Nov 29Third quarter 2023 earnings released: EPS: CA$0 (vs CA$0 in 3Q 2022)Third quarter 2023 results: EPS: CA$0 (in line with 3Q 2022). Net loss: CA$68.4k (loss narrowed 29% from 3Q 2022).
Reported Earnings • Sep 01First half 2023 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in 1H 2022)First half 2023 results: CA$0.003 loss per share (improved from CA$0.008 loss in 1H 2022). Net loss: CA$379.0k (loss narrowed 78% from 1H 2022).
공시 • Jul 06Steep Hill Inc. Announces Demise of Director, David WaltersThe Board of Directors and management of Steep Hill Inc. announce that Director, David Walters, has passed away. David joined the board at the time of the go-public transaction of Canbud Distribution Corp., (now called Steep Hill Inc) and during his time with the company provided oversight as Audit Committee chair. On behalf of the Board of Directors and team, company extend the deepest condolences to David's family and to all those who came to know him as a colleague and as a friend.
공시 • Jun 04Steep Hill Inc. Announces Chief Financial Officer ChangeSteep Hill Inc. announced that Raj Ravindran has resigned as the company's Chief Financial Officer to pursue other endeavors. Raj was one of the co-founders of Canbud Distribution Corp., the entity that culminated into Steep Hill following the acquisitions made in 2021 and 2022. The board announced the appointment of Ms. Patricia Militello as Interim CFO. Since fourth quarter of 2021, Ms. Militello has been instrumental in leading the finance and accounting team as an external consultant. Ms. Militello is expected to lend her expertise as Steep Hill continues on the path of restructuring and exploring strategic alternatives.
공시 • May 19Steep Hill Inc., Annual General Meeting, Jul 28, 2023Steep Hill Inc., Annual General Meeting, Jul 28, 2023.
Board Change • Dec 02High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 3 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Apr 27High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Mar 07High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. Founder, CFO & Director Raj Ravindran is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.